Sucampo Pharma's (SCMP +6.1%) supplemental new drug application for its Rescula treatment to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension receives approval from the FDA. SCMP says it intends to commercialize the drug in Q1 2013.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs